Literature DB >> 19483172

38-year-old woman with abnormal liver enzymes and hyperlipidemia.

Marina G Silveira1, Keith D Lindor.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19483172      PMCID： PMC2688629          DOI： 10.1016/S0025-6196(11)60587-9

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  24 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid.

Authors:  P Angulo; K D Lindor; T M Therneau; R A Jorgensen; M Malinchoc; P S Kamath; E R Dickson
Journal:  Liver       Date:  1999-04

3.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

4.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

Authors:  R E Poupon; K D Lindor; K Cauch-Dudek; E R Dickson; R Poupon; E J Heathcote
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

5.  Sjögren's syndrome in patients with primary biliary cirrhosis.

Authors:  E V Tsianos; J H Hoofnagle; P C Fox; M Alspaugh; E A Jones; D F Schafer; H M Moutsopoulos
Journal:  Hepatology       Date:  1990-05       Impact factor: 17.425

6.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.

Authors:  K D Lindor; E R Dickson; W P Baldus; R A Jorgensen; J Ludwig; P A Murtaugh; J M Harrison; R H Wiesner; M L Anderson; S M Lange
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

Review 7.  Primary biliary cirrhosis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

8.  Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years.

Authors:  Martin Prince; Amanda Chetwynd; Wendy Newman; Jane V Metcalf; Oliver F W James
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

9.  When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

Authors:  Claudia O Zein; Paul Angulo; Keith D Lindor
Journal:  Clin Gastroenterol Hepatol       Date:  2003-03       Impact factor: 11.382

10.  Autoimmune associations in primary biliary cirrhosis.

Authors:  K S Culp; C R Fleming; J Duffy; W P Baldus; E R Dickson
Journal:  Mayo Clin Proc       Date:  1982-06       Impact factor: 7.616
View more
  1 in total

1.  Primary biliary cirrhosis presenting with gastritis, hyperlipidemia and marked weight loss.

Authors:  Moushumi Lodh; Debkanta Pradhan; Abhishek Mukherjee
Journal:  Indian J Clin Biochem       Date:  2011-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.